FDA
approval
· 2022-01-25
FDA Approved: KIMMTRAK — Original Application (Immunocore Commercial LLC)
Summary
FDA approved KIMMTRAK (tebentafusp) in an original application for adults with unresectable or metastatic uveal melanoma, marking the first approval for this th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for KIMMTRAK (TEBENTAFUSP)